...
【24h】

Analysis of angiotensin II receptor antagonist and protein markers at microliter level plasma by LC-MS/MS.

机译:通过LC-MS / MS在微升水平血浆中分析血管紧张素II受体拮抗剂和蛋白质标志物。

获取原文
获取原文并翻译 | 示例
           

摘要

An analytical method based on a green approach is proposed for clinical analysis. The proposed procedure involves the reduction of the sample preparation steps, the amounts of reagents and organic solvents. This simple and sensitive method for the analysis of clinical drug and biomarkers in human plasma was developed using LC connected to tandem mass spectrometry (LC-MS/MS) with a nanospray ion source. In this study, the desired drug and proteins were separated on a 5 and 10 cm RP C18 nano-flow column. Undesired polar substances in human plasma were washed out by using ACN:1% FA=20:80 (v/v) as the loading mobile phase for drug analysis and good linearity was attainable. Only a small volume of human plasma (10 microL) was utilized for the monitoring of drug plasma concentration and significant proteins under clinical studies. All the sample preparation procedures and the analytical scheme were at microliter level. This strategy would lower the consumption of reagents and organic solvents and make a contribution toward the goal of reduction of pollution from analytical methods in general.
机译:提出了一种基于绿色方法的分析方法进行临床分析。拟议的程序涉及减少样品制备步骤,减少试剂和有机溶剂的量。这种使用液相色谱仪通过纳米喷雾离子源连接到串联质谱(LC-MS / MS),开发了一种用于分析人血浆中临床药物和生物标志物的简单而灵敏的方法。在这项研究中,所需的药物和蛋白质在5和10 cm RP C18纳米流色谱柱上分离。使用ACN:1%FA = 20:80(v / v)作为药物分析的上载流动相,可以洗净人体血浆中不需要的极性物质,并且可以获得良好的线性。在临床研究中,仅使用少量的人血浆(10 microL)来监测药物血浆浓度和重要蛋白质。所有样品制备程序和分析方案均为微升水平。这种策略将降低试剂和有机溶剂的消耗,并有助于实现总体上减少分析方法污染的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号